ZVRA
NASDAQ · Pharmaceuticals
Zevra Therapeutics Inc
$9.38
+0.23 (+2.51%)
Open$9.17
Previous Close$9.15
Day High$9.39
Day Low$9.14
52W High$13.16
52W Low$6.19
Volume—
Avg Volume756.6K
Market Cap508.35M
P/E Ratio14.39
EPS$0.59
SectorPharmaceuticals
Analyst Ratings
Strong Buy
14 analysts
Price Target
-43.1% upside
Current
$9.38
$9.38
Target
$5.34
$5.34
$3.67
$5.34 avg
$6.76
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 28.93M | 30.86M | 109.96M |
| Net Income | -129,286,637 | -124,101,933 | 24.47M |
| Profit Margin | -446.9% | -424.5% | 22.3% |
| EBITDA | -96,257,990 | -97,531,026 | 54.29M |
| Free Cash Flow | — | — | 22.49M |
| Rev Growth | -6.2% | -6.2% | -4.5% |
| Debt/Equity | 1.50 | 1.50 | 0.54 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $916.31 | +1.47% | 46.4 | 957.52B |
| JNJ | Johnson & Johnson | $239.93 | +1.98% | 22.2 | 594.00B |
| MRK | Merck & Co. Inc. | $119.37 | +2.58% | 16.5 | 301.17B |
| PFE | Pfizer Inc. | $27.28 | +1.19% | 19.7 | 153.36B |
| BMY | Bristol-Myers Squibb Co | $58.94 | +2.70% | 16.5 | 116.58B |
| ZTS | Zoetis Inc | $116.71 | +0.67% | 21.5 | 57.37B |